<p>(A) Correlation of experimental and predicted immunogenicity of each peptide. The experimental immunogenicity score of a peptide is defined as the linear combination of the individual experimentally determined relative HLA binding affinity of each HLA allele h ∈ H weighted by the HLA allele frequency. (B) Correlation of experimental and predicted immunogenicity of the whole redesigned region. The summarized immunogenicity score of the whole region is the linear combination of the overlapping peptides used to reconstruct the region, normalized by total number of peptides used. The predicted immunogenicity scores per peptide were computed according to our immunogenicity objective function. The red lines are a fitted linear regression and t...
Since CD8+ T cell response is crucial to combat intracellular infections and cancer, identification ...
Copyright © 2013 Sinu Paul et al.This is an open access article distributed under the Creative Commo...
<p>The major histocompatibility complex of class II (MHCII) immunopeptidome represents the repertoir...
<p>Pareto front of de-immunized designs in percent change compared to the wild type with k = 1,2,3 m...
<p>(A) Immunogenicity screening for three DRB1 alleles (DRB1*15:01, DRB1*03:01 and DRB1*07:01) with ...
BackgroundPrediction of T cell immunogenicity is a topic of considerable interest, both in terms of ...
<p>We aim to describe the immunogenicity of a peptide:HLA combination as a number between 0 and 1. F...
Immunogenicity is a major problem during the development of biotherapeutics since it can lead to rap...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Immunogenicity is a major problem during the development of biotherapeutics since it can lead to rap...
<p>(A) <i>In vivo</i> immunogenicity as predicted by the MHC I immunogenicity tool of the IEDB for t...
Since CD8+ T cell response is crucial to combat intracellular infections and cancer, identification ...
Since CD8+ T cell response is crucial to combat intracellular infections and cancer, identification ...
Copyright © 2013 Sinu Paul et al.This is an open access article distributed under the Creative Commo...
<p>The major histocompatibility complex of class II (MHCII) immunopeptidome represents the repertoir...
<p>Pareto front of de-immunized designs in percent change compared to the wild type with k = 1,2,3 m...
<p>(A) Immunogenicity screening for three DRB1 alleles (DRB1*15:01, DRB1*03:01 and DRB1*07:01) with ...
BackgroundPrediction of T cell immunogenicity is a topic of considerable interest, both in terms of ...
<p>We aim to describe the immunogenicity of a peptide:HLA combination as a number between 0 and 1. F...
Immunogenicity is a major problem during the development of biotherapeutics since it can lead to rap...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Background<p>Prediction of T cell immunogenicity is a topic of considerable interest, both in terms ...
Immunogenicity is a major problem during the development of biotherapeutics since it can lead to rap...
<p>(A) <i>In vivo</i> immunogenicity as predicted by the MHC I immunogenicity tool of the IEDB for t...
Since CD8+ T cell response is crucial to combat intracellular infections and cancer, identification ...
Since CD8+ T cell response is crucial to combat intracellular infections and cancer, identification ...
Copyright © 2013 Sinu Paul et al.This is an open access article distributed under the Creative Commo...
<p>The major histocompatibility complex of class II (MHCII) immunopeptidome represents the repertoir...